Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab

Authors:

Abstract
Based on the available literature and the experiences collected from adult and paediatric patients treated in Switzerland, the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network provides a practical guidance for the management of breakthrough bleeding events and surgery in patients with haemophilia A without inhibitors treated with emicizumab.